We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$8.38B
AUM Growth
+$1.92B
Cap. Flow
+$1.58B
Cap. Flow %
18.83%
Top 10 Hldgs %
13.01%
Holding
3,099
New
763
Increased
795
Reduced
700
Closed
736

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$34.9M
2
CL icon
Colgate-Palmolive
CL
+$33.1M
3
PSX icon
Phillips 66
PSX
+$31.7M
4
SPGI icon
S&P Global
SPGI
+$27.7M
5
VMW
VMware, Inc
VMW
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 15.29%
2 Healthcare 9.42%
3 Industrials 9.09%
4 Consumer Discretionary 8.48%
5 Financials 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGF
2301
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$87.7K ﹤0.01%
2,106
-62
-3% -$2.74K
PTRA
2302
DELISTED
Proterra Inc. Common Stock
PTRA
$85.5K ﹤0.01%
71,234
CELL
2303
DELISTED
PhenomeX Inc. Common Stock
CELL
$85.5K ﹤0.01%
174,397
-20,600
-11% -$16.9K
CURO
2304
DELISTED
CURO Group Holdings Corp.
CURO
$84.4K ﹤0.01%
62,536
CLYM
2305
Climb Bio
CLYM
$827M
$83.2K ﹤0.01%
29,706
PGEN icon
2306
Precigen
PGEN
$2.45B
$82.2K ﹤0.01%
71,464
SMMT icon
2307
Summit Therapeutics
SMMT
$12B
$80.6K ﹤0.01%
32,103
+16,988
+112% +$31K
ALT icon
2308
Altimmune
ALT
$570M
$79.4K ﹤0.01%
+22,501
New +$101K
SLND.WS icon
2309
CALL
Southland Holdings Warrants
SLND.WS
$78.8K ﹤0.01%
75,000
CTMX icon
2310
CytomX Therapeutics
CTMX
$760M
$76.9K ﹤0.01%
44,730
SCOR icon
2311
Comscore
SCOR
$108M
$75.6K ﹤0.01%
4,665
IREN icon
2312
Iris Energy
IREN
$15.6B
$70.8K ﹤0.01%
15,188
BBAI icon
2313
BigBear.ai
BBAI
$1.56B
$70.7K ﹤0.01%
+30,090
New +$76.3K
LTCH
2314
DELISTED
Latch, Inc. Common Stock
LTCH
$70.6K ﹤0.01%
50,786
NCMI icon
2315
National CineMedia
NCMI
$209M
$67.1K ﹤0.01%
19,921
GAN
2316
DELISTED
GAN Ltd
GAN
$66.5K ﹤0.01%
40,536
BIRD icon
2317
Smartbird Inc
BIRD
$30.2M
$63K ﹤0.01%
2,500
ACCO icon
2318
Acco Brands
ACCO
$399M
$62.5K ﹤0.01%
+12,002
New +$60.3K
ATAI icon
2319
AtaiBeckley Inc
ATAI
$2.68B
$60.2K ﹤0.01%
35,000
EMKR
2320
DELISTED
Emcore Corp
EMKR
$58.5K ﹤0.01%
7,779
GOSS icon
2321
Gossamer Bio
GOSS
$86.8M
$55.8K ﹤0.01%
46,464
ALLO icon
2322
Allogene Therapeutics
ALLO
$714M
$54K ﹤0.01%
+10,863
New +$58.8K
THRN
2323
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$51.5K ﹤0.01%
10,961
CNSL
2324
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$50.7K ﹤0.01%
13,231
-63,617
-83% -$229K
BRLT icon
2325
Brilliant Earth
BRLT
$22.1M
$49.7K ﹤0.01%
12,811
-2,050
-14% -$7.78K

Similar funds

Tudor Investment Corp's Q2 2023 Portfolio in Review

As of Q2 2023, Tudor Investment Corp held 3,099 positions worth $8.38B, up 30% from $6.46B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Tudor Investment Corp deployed $1.58B of net new capital in Q2 2023, opening 763 new positions and adding to 795 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 340,004 shares worth $65.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Colgate-Palmolive, an estimated $33.1M trimmed.

  • Tudor Investment Corp's largest Q2 2023 buy was Seagen Inc. Common Stock: 340,004 shares worth $65.4M.
  • Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $77.6M increase.
  • Tudor Investment Corp's biggest Q2 2023 reduction was Colgate-Palmolive, cutting an estimated $33.1M.
  • Tudor Investment Corp fully exited Johnson & Johnson in Q2 2023, selling an estimated $34.9M.
  • Tudor Investment Corp's ten largest holdings make up 13% of its $8.38B portfolio in Q2 2023.
  • Tudor Investment Corp opened 763 new positions and closed 736 in Q2 2023.
  • Tudor Investment Corp's portfolio value rose 30% quarter-over-quarter to $8.38B.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.